Prolastin c 1,000 MG/20 ML VLS
Ended Awarded
- Contract number
- SPE2DB25FX7Y1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,150
Award facts
- Contract value 100% obligated
- $18,149.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,149.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The award represents a discrete purchase order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499.99 million and valid through November 2026, which authorizes the issuance of delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contract awards from the Defense Logistics Agency across diverse medical product categories. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. Prolastin C, an alpha-1 protease inhibitor used for the treatment of alpha-1 antitrypsin deficiency, reflects the company's capability to supply specialized pharmaceutical products essential to military medical operations and personnel health maintenance.
Quick answers
Who was awarded contract SPE2DB25FX7Y1?
SPE2DB25FX7Y1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FX7Y1 worth?
The government has obligated $18,150 on SPE2DB25FX7Y1.
Is contract SPE2DB25FX7Y1 an order under another contract?
Yes. SPE2DB25FX7Y1 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Y1 competed?
The extent of competition for SPE2DB25FX7Y1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award